The present invention is directed to chromenone compounds of formula (II),pharmaceuticallyacceptable salts, solvates thereof, and the composition comprising thecompounds or the like. They canbe used to modulating the function of estrogen receptor ER-.alpha.36preventing and/or treating the estrogenrelated diseases, such as breast cancer, leukemia, and liver cancer.